Washington – Senate Finance Committee Chairman Chuck Grassley
(R-Iowa) today issued the following statement after the Department of Health
and Human Services announced new final rules regarding prescription drug
pricing.
“While
I still need to review the details of these new rules, I’m not surprised the
administration is taking action. Drug prices have been a problem for patients
and taxpayers for years. Action was clearly called for and I’m glad something
is being done to combat the problem.
“The
folks who have concerns about the impacts on premiums or innovation should come
back to Congress and work to reach a true legislative compromise. The best path
has always been through legislation and the door has been open, but Big Pharma
and its allies have stonewalled progress. The Grassley-Wyden prescription drug
bill strikes just the right balance of comprehensive reform that will lower
drug costs for patients and taxpayers while preserving innovation. I’d
encourage both stakeholders and Democratic leadership to come back to the
table.”
-30-